We hypothesized that pulmonary vasorelaxation mediated by receptors th
at require generation of cyclic adenosine monophosphate (cAMP) is impa
ired in endotoxin-induced acute lung injury. The purpose of this study
was to determine the effect of endotoxin on the following pathways of
pulmonary vasorelaxation that require the generation of cAMP: 1) beta
-adrenoreceptor stimulation (response to isoproterenol, ISO), 2) P-2 p
urinoreceptor stimulation (response to adenosine diphosphate, ADP), 3)
H-2-histamine receptor stimulation (response to dimaprit), 4) adenosi
ne A(2) receptor stimulation (response to adenosine, ADO), 5) type 2 E
prostaglandin (EP(2)) receptor stimulation (response to prostaglandin
E(1), PGE(1)), and 6) direct adenylate cyclase stimulation (response
to forskolin, FSK). We used isolated pulmonary artery rings harvested
from rats injected with endotoxin or saline. We found that endotoxin i
mpaired the response to beta-adrenoreceptor stimulation (ISO) and P-2
purinoreceptor stimulation (ADP). Endotoxin converted the vasorelaxant
effect of H-2-histamine receptor stimulation (dimaprit) to vasoconstr
iction. On the other hand, the response to A(2) receptor stimulation (
ADO) and EP(2) receptor stimulation (PGE(1)) was normal. The dose resp
onse to direct adenylate cyclase stimulation (FSK) was the same as con
trol except at a single concentration (10(-7) M). These data suggest t
hat endotoxin causes selective impairment of pulmonary vasorelaxation
through receptors coupled to cAMP generation. This impaired pulmonary
vasorelaxation may contribute to the increased pulmonary vascular resi
stance seen in acute lung injury. These data may lead to therapy that
will prevent or improve the pathophysiologic pulmonary circulation in
acute lung injury.